FAQ on FerriScan asked by clinical communities

Similar documents
FerriScan provides an accurate assessment of body iron stores

The safe and accurate measurement of liver iron concentration. Information for Patients

Comparison between different software programs and techniques for liver iron concentration assessment with MRI in thalassemic patients

SleepImage Website Instructions for Use

IT and Information Acceptable Use Policy

NJ CBCT Regulation FAQ & Assistance

Clinical Commissioning Policy Proposition: Treatment of iron overload for transfused and non transfused patients with chronic inherited anaemias

Australian Sonographer Accreditation Registry (ASAR) Policy & Procedure 9 - Annual Reporting Requirements for Accredited Sonography Courses

Why measure heart iron?

1.5 Tesla and 3 Tesla Magnetic Resonance Imaging (MRI) Guidelines for the Senza System (IPG1000 and IPG1500)

NONE. Disclosures. Accreditation Update

University College Hospital

Aer ODE B3-20. Database System for GEX B3 Dosimetry. Aérial. Optical Dosimetry Equipment. (gamma and/or electron beam versions)

Canadian Grain Commission

ASAR. Australian Sonographer Accreditation Registry. Form 1-2. Application guide for entry onto the register of Accredited Student Sonographers

ISO and the Delivery of Competent NDT Services

STANDARD OPERATING PROCEDURE (SOP)

Physician s Compliance Guide

COLUMBIA UNIVERSITY INSTITUTIONAL REVIEW BOARD GUIDANCE ON ELECTRONIC INFORMED CONSENT

Exjade q (deferasirox): Important information for patients about your treatment and possible side effects

Darwin Marine Supply Base HSEQ Quality Management Plan

1.5 Tesla and 3 Tesla Magnetic Resonance Imaging (MRI) Guidelines for the Senza System (IPG1000 and IPG1500)

Implementation Guide for the DoseControl Dosimetry System

DIABETES BLOOD GLUCOSE MONITORING AT HOME (ADULTS)

Iron Overload in Sickle Cell Disease Review of Cause and Treatment

Cannabis for Medical Purposes

See Important Reminder at the end of this policy for important regulatory and legal information.

INVESTOR PRESENTATION

FACT SHEET Q Fever and the Australian Q Fever Register

COMPETENT AUTHORITY (UK) MEDICAL DEVICES DIRECTIVES GUIDANCE NOTES FOR MANUFACTURERS OF DENTAL APPLIANCES

ISO 13485:2016 MEDICAL DEVICES QMS TRANSITION GUIDE

Name of Event: Date of Event: Details of Event Organiser: [Name, Address, Contact number, ]

D9995 and D9996 ADA Guide to Understanding and Documenting Teledentistry Events

On successful completion of the Unit the learner will be able to:

Recommendations for Regulators Cannabis Operations

Consensus view on choice or iron chelation therapy in transfusional iron overload for inherited anaemias

15. Procuring, processing and transporting gametes and

Flu Vaccination Clinics

Thalassaemia and Abnormal Haemoglobins in Pregnancy

CT Quality Control Manual FAQs

Quality Management System Certification. Understanding Quality Management System (QMS) certification

Melinda Trimble RPSGT, RST

CHE8000 Major Research Project A. The Complementary Medicines Reforms and Its Impact to the Complementary Medicine Industry and the Consumer

LEAF Marque Assurance Programme

DIABETES BLOOD GLUCOSE MONITORING AT HOME (ADULTS)

Non-Prescription Medicinal Products Containing Codeine: Guidance for Pharmacists on Safe Supply to Patients

Niche News August 2017 August 2017

Frequently Asked Questions

Lumbar, cervical and thoracic spine surgery (open, closed or minimally invasive) Adult deformity surgery Implantable infusion pump insertion

Australian Sonographer Accreditation Registry (ASAR) Policy & Procedures 6 - Reporting Accreditation Decisions

making a referral for breast imaging Standard Operating Procedure

BMA INFORMATION BULLETIN No. 23. International Safety Management (ISM) Code

Asia-Pacific Bariatric Surgery Devices Market Outlook to 2020

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQ s) For Sunshine Health Providers

Service Specification & Contract Intermediate Stop Smoking Service & Voucher fulfilment - Pharmacy Newcastle

DEFERASIROX IN THE TREATMENT OF TRANSFUSIONAL IRON OVERLOAD IN THALASSAEMIA MAJOR AND OTHER ANAEMIAS (April 2011)

Medical gap arrangements - practitioner application

Clinical Commissioning Policy: Chemotherapy Algorithms for Adults and Children. January 2013 Reference: NHS England XXX/X/X.

Lakshy Management Consultant Pvt. Ltd.

Exjade (tablets for oral suspension), Jadenu (deferasirox)

CARIBX (UK) LIMITED. Environmental, Health and Safety Management System. Revision: 00 APRIL 2011

BRIC Transurethral Resection of the Prostate (TURP) Procedures Outlook to 2020

28 th September Author Jeremy Gilbert Bariatric Nurse Specialist

Corporate Presentation Fourth Quarter 2017

AAPM Annual Meeting. ACR Accreditation Update in CT

British Geriatrics Society

Transjugular intrahepatic portosystemic shunt (TIPS) Information for patients Sheffield Vascular Institute

Prescriber and Pharmacy Guide for the Tracleer REMS Program

School Based Services Date: April 1, 2018 Page 20

Falsified Medicines Directive (FMD) Dispensing Doctors Association Wednesday 18-Oct-17 Jerome Bertin

instadose dosimeters Dosimetry Services Division

Professional body composition analysis: BODYSTAT I500 THE SCIENCE BEHIND CLINICAL BODY ASSESSMENT.

CAPACITY OF THE HEALTHCARE SYSTEM TO INCREASE PROVISION OF HIV TESTING

Improvement of Accuracy of Breast Cancer Screening

Itamar Medical. December Investors Presentation.

5 Diagnosis. Timely diagnosis. Back to contents

Welcome to presentation By Sanjay Punjabi Lead Auditor for ISO 9001, ISO 14001, OHSAS & BS 7799

RADIATION SAFETY. Safely Working with Radioactive Materials. 27 Nov - 01 Dec 2016, Dubai I Sep 2017, Dubai

HIV Care & Treatment Program STATE OF OREGON

FirstCare Health Plans (FirstCare) is on track to be ICD-10 ready by the October 1, 2015 deadline.

Alcohol & Drug Practice

STANDARD OF PRACTICE. Dental CT Scanners CONTENTS. April 2011

Haemostasis Registry. A Register to record all off-label use of recombinant activated Factor VII in Australia and New Zealand

now a part of Electronic Mammography Exchange: Improving Patient Callback Rates

Screening Mammograms: Questions and Answers

MRI FAQs. After reading these documents and checking your protocols, you can apply online here:

Corporate Presentation. August 2016

Setting The setting was secondary care. The economic study was carried out in the USA.

IAF Mandatory Document. Requirements for the Migration to ISO 45001:2018 from OHSAS 18001:2007 (IAF MD 21:2018)

Activity Report March 2013 February 2014

Approval of Dosimetry Services in Ireland Guidelines for Applicants

Cardiac Magnetic Resonance Imaging (MRI)

Inspections, Compliance, Enforcement, and Criminal Investigations

I trust you are well, it is pleasing to see that your campaign is providing positive results.

EU5 Bariatric Surgery Procedures Outlook to 2020

Radiation Safety. Safely Working with Radioactive Materials September 2017 Dubai, U.A.E.

EXPRESSION OF INTEREST New Horizons Advancing Pediatric HIV Care Donation Program

Having MR Small Bowel (MR Enterography)

Transcription:

FAQ on FerriScan asked by clinical communities We measure cardiac T2* of our patients, why is it important to measure liver iron concentration (LIC) as well? Measuring cardiac T2* is important as a significant number of transfused patients die from cardiac complications. However, the risk of cardiac complications is decreased if the total body iron store is accurately monitored and treated. The key reasons why LIC measurement is important are: 1) The LIC value is the best measurement of total body iron stores. [1] 2) Under normal circumstances, the liver is the primary site of iron storage. However, once a certain threshold of liver iron is exceeded, iron begins to accumulate in the heart and other organs. [4] 3) High LIC acts as an early warning sign of possible future cardiac complications, as it may prospectively predict cardiac iron loading and cardiac disease.[2,3] 4) FerriScan enables clinicians to determine the effectiveness of chelation therapy and when to adjust the therapy accordingly, minimising the risk of iron loading in other organs. How does FerriScan work? FerriScan is an MRI-based technology that works by analysing abdominal images acquired by MRI scanners that have been set up with the FerriScan protocol. This requires no new equipment, software or training and is provided as an image analysis service charged only per analysis. The image data acquired during the MRI scan are uploaded to the Company s secure server for analysis at the central FerriScan Service Centre. Within two business days a Liver Iron Concentration (LIC) report is produced and made available to the MRI Centre. What information does the LIC report provide? The LIC report provides: the patient s liver iron concentration a table to indicate the clinical relevance of their LIC measurement a map of the iron distribution across their liver a histogram showing indicative iron distribution where available, historical data showing the patient s progress over time Can FerriScan be used to assess iron in the heart? FerriScan itself does not measure iron in the heart. However, a cardiac T2* measurement can also be provided in conjunction with a FerriScan where the MRI scanner is suitably equipped to capture cardiac data.

What are the advantages of using FerriScan? Proven accuracy Reliability across different centres and scanners, in the presence of inflammation, fibrosis or cirrhosis Standardised image analysis process A quality-controlled process. All FerriScan analyses are conducted in an ISO-13485 certified central facility MRI scanners using FerriScan are regularly assessed against a Phantom(quality standard) to ensure reliability Why is FerriScan better than alternative tests? FerriScan vs liver biopsy Liver biopsy is an invasive and painful procedure which cannot be performed frequently There is a high risk of sampling error with biopsy due to significant heterogeneity of iron concentrations throughout the liver The biopsy results may also be affected by the presence of other liver diseases Liver biopsy may be contraindicated for some patients FerriScan vs liver T2* Liver T2* refers to a variety of methodologies, each of which uses a calibration curve specific to that methodology and not transferable between methods. This renders the interpretation of T2* data into LIC measurements prone to error, particularly at high levels of iron loading. Liver T2* methods have generally been calibrated on one scanner only, with small patient populations, so inter-scanner and inter-operator variability is a significant issue. FerriScan was calibrated on five different makes or models of scanner with a patient population of 105 and independently validated in a further patient population of 233, across a range of iron-loading conditions [6, 7]. Liver T2* methodologies lack the standardisation and validation of FerriScan. All FerriScan sites must verify their scanner set-up against a set of standards prior to starting patient scanning. A reverification is then performed every 12 months to ensure the scanner settings remain accurate. Studies have indicated that FerriScan results are not affected by the presence of liver fibrosis. Liver T2* requires a patient breath-hold, which may be difficult for paediatric or anxious patients to achieve, particularly if sedation is required. FerriScan requires no breath-hold and is therefore not impacted by these issues. FerriScan vs Rennes (Gandon) method The Rennes method demonstrates only a weak correlation with liver biopsy in patients with a high LIC (above 11.2 mg/g dw) [5]. In comparison, FerriScan has regulatory clearance to measure LIC up to 43 mg/g/dw.

FerriScan vs Serum Ferritin There is a weak correlation between serum ferritin and LIC as results are confounded by factors such as inflammation and infection. Serum ferritin is only a surrogate marker for LIC and therefore can only be used for monitoring trends in patients iron loading. Is FerriScan approved by regulatory bodies? FerriScan has the following regulatory clearances: - In the US by the FDA (Food and Drug Administration); - In Australia by the TGA (Therapeutic Goods Administration); - In Europe (CE Mark), which covers 27 countries. In the rest of the world, FerriScan complies with local regulations. Resonance Health has an internal approval process to ensure all MRI centres wishing to offer FerriScan can legally and technically do so. The FDA has mandated the use of FerriScan or biopsy in patients with Non-Transfusion Dependent Thalassaemia who are being treated with the iron chelator Exjade, a medication which helps reduce body iron levels. How long does FerriScan take? The scan time for FerriScan is approximately 9-10 minutes. Results are then analysed and returned to the MRI Centre within a target time of two business days. Is FerriScan clinically validated? Yes. FerriScan was calibrated on a range of different makes or models of scanner with a patient population of 105 and independently validated in a further patient population of 233, across a range of different makes of MRI scanners, in different countries and in patients with a variety of iron-loading conditions. [6, 7] How would this test help me provide better services to my patient? The accurate assessment of iron loading provided by FerriScan helps inform clinician s decisions on patient management. The LIC result is provided with further information to provide clinical relevance to the result, including graphics to illustrate the distribution and range of iron loading across the liver section. The historical information provided on FerriScan LIC Reports has been found by clinicians to be a very useful aid to motivating patient compliance with their treatment regime. Where is FerriScan available? FerriScan is available in over 30 countries at more than 220 MRI centres around the world. Existing locations can be found on our website /find a centre/all Does the MRI centre need to buy/install new software on the MRI scanner? No. FerriScan is an image analysis protocol that can be implemented on most 1.5T MRI scanners using the scanner s own settings. A Phantom Pack (scanner setup verification tool) is provided to verify the scanner and patient scanning may then commence. FerriScan is provided as an image analysis service, charged only per analysis.

Is FerriScan reimbursed by Health Authorities or Private Insurers in my country? In most countries the referring clinician will be able to advise patients about possible reimbursement. FerriScan is reimbursed in the following countries. USA Some insurers offer cover on a pre-approved or case by case basis in certain states. Medicare / Medicaid coverage is also available for some patients. Referring clinicians or FerriScan MRI centres have more information available on local reimbursement policies. Canada FerriScan is reimbursed by the Out-of-country health service in a number of territories. In Ontario, the treating clinician must forward an application of each patient to the individual provinces Ministry of Health (MOH) for approval. Once approved, the MOH will grant a timeframe for the patient to have their FerriScan. Other territories have slightly different arrangements. United Kingdom Many UK hospitals have gained reimbursement from their NHS Trust and referring clinicians or MRI centres will have more information on accessing this. Germany Case by case reimbursement for FerriScan may be available for certain patients. Australia While Medicare reimbursement is not available, FerriScan can in some cases be accessed through State-funded hospital services. New Zealand FerriScan is reimbursed in New Zealand by some District Health Boards. Do MRI Centres need to receive any special training? No. An instruction manual is provided to assist technicians set up the FerriScan protocol and scan the Phantom Pack (scanner setup and verification tool). Should further assistance be required, the FerriScan Service Centre will contact them by telephone or email to resolve any questions and ensure the centre is able to provide FerriScan services to their patients. How is security of patient data assured? Resonance Health has undertaken extensive measures to ensure the security of patient data. The measures include data and internet security, staff training, de-identification of patient data, quality control procedures, physical security systems within the Service Centre, and adherence to: Medical Technology Association of Australia (MTAA) Code of Practice AdvaMed Advanced Medical Technology Association (USA) Code of Ethics

Resonance Health utilises its proprietary secure web-based system (FAST) for data upload, tracking, and result download. All data transfer to and from the FAST system is secured. Access to the system is restricted to authorised personnel by unique login IDs and passwords. Resonance Health's infrastructure is compliant with: Health Insurance Portability and Accountability Act (HIPAA) (USA) Health Information Technology for Economic and Clinical Health (HITECH) Act (USA) Data Protection Act (UK) Australian Privacy Act 1988 Resonance Health is also a registered data controller in the UK registered with the Information Commissioner s Office. What quality controls are in place? All aspects of Resonance Health s service provision are performed in accordance with our certified quality management system. From the recruitment and training of staff, to the receipt of data and the quality control checking of results, documented procedures are followed and records retained. A primary focus of the company is the continual improvement of the quality management system and the service we provide, through monitoring and actioning of customer feedback, internal audits, and a corrective and preventative action system. Our quality management system is certified to the following international standard: ISO 13485: Medical Devices - Quality Management Systems - Requirements for Regulatory Purposes. How cost-effective is FerriScan? There are no set up costs for FerriScan; there is no equipment to purchase, software to install or training to be completed. FerriScan is charged per analysis only. A FerriScan requires no contrast agent, recovery time and generally no sedation. By providing the most accurate and reliable measurement across all ranges of LIC normally encountered in clinical practice, FerriScan enables clinicians to optimise patient s treatment, basing dosage decisions on the patient s measured level of iron loading. Which clinical authorities recommend the use of FerriScan? UK Standards of Care for Thalassaemia 2016 TIF Guidelines for the Clinical Management of Thalassaemia 3nd Edition 2014 2012 Thalassemia Standards of Care Guidelines Northern California Comprehensive Thalassemia Network and Children's Hospital, Oakland 2012 Guidelines for the Care of Patients in the UHN Red Blood Cells Disorders Program University Health Network, Toronto General Hospital, Canada Cooley s Anemia Foundation 2012 Position Statement on MRI-Based Hepatic Iron Assessment Methods

2011 Australian Guidelines for the assessment of iron overload and iron chelation in transfusiondependent thalassaemia major, sickle cell disease and other congenital anaemias. 2008 Standards for the Clinical Care of Adults with Sickle Cell Disease in the UK, UK Sickle Cell Society Practice Guidelines for the Management of Iron Overload, 2008 Italian Society of Hematology Canadian Practice Guidelines for MDS, 2008 How do I get FerriScan established at my MRI Centre? Ask your Radiologist to complete an MRI Centre Scanner Details Form (/information-for-radiology-centres/mri-scanner-details-form.html) to establish that their MRI scanner is suitable for FerriScan. Once this has been received by Resonance Health, we will work with the MRI Centre to verify their scanner for the FerriScan protocol and enable them to submit FerriScan image data for analysis. References: [1] Angelucci E et al, Hepatic iron concentration and total body iron stores in thalassemia major. NEng J Med 2000; 343:327-31 [2] Telfer P, et al, Hepatic iron concentration combined with long-term monitoring of serum ferritin to predict complication of iron overload in thalassemia major. British Journal of Haematology 2000; 110:971-77 [3] Noetzli L et al, Longitudinal analysis of heart and liver iron in thalassaemia major. Blood 2008; 112:2973-78 [4] Jensen PD et al, Evaluation of myocardial iron by magnetic resonance imaging during iron chelation therapy with deferrioxamine: indication of close relation between myocardial iron content and chelatable iron pool. Blood 2003; 101:4632-39. [5] Rose C et al, Liver iron content assessment by routine and simple magnetic resonance imaging procedure in highly transfused patients. Eur J Haematology 2006; 77:145-49 [6] St Pierre T et al, Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. Blood 2005; 105:855-61. [7] St Pierre T et al, Multi-Center Validation of Spin-Density Projection-Assisted R2-MRI for the Noninvasive Measurement of Liver Iron Concentration. Magn Reson Med. (2013), doi: 10.1002/mrm.24